Published in
American Society of Hematology, Blood, 20(127), p. 2451-2459, 2016
DOI: 10.1182/blood-2015-12-688705
Links
- ORCID
- American Society of Hematology | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Journal article published in 2016 by
Nicolas Duployez,
Alice Marceau-Renaut,
Nicolas Boissel,
Arnaud Petit 
,
Maxime Bucci,
Sandrine Geffroy,
Hélène Lapillonne,
Aline Renneville,
Christine Ragu,
Martin Figeac,
Karine Celli-Lebras,
Catherine Lacombe,
Jean-Baptiste Micol,
Omar Abdel-Wahab,
Pascale Cornillet
and other authors.
,
Maxime Bucci,
Sandrine Geffroy,
Hélène Lapillonne,
Aline Renneville,
Christine Ragu,
Martin Figeac,
Karine Celli-Lebras,
Catherine Lacombe,
Jean-Baptiste Micol,
Omar Abdel-Wahab,
Pascale Cornillet
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Recurrent mutations in chromatin modifiers and cohesin were observed in t(8;21) AML, but not inv(16) AML. t(8;21) AML patients with mutations in kinase signaling plus chromatin modifiers or cohesin members had the highest risk of relapse.